150 related articles for article (PubMed ID: 34888375)
1. Molecular Cloning of Alternative Splicing Variants of the Porcine
Zhu J; Chen Z; Dai Z; Zhou X; Wang H; Li X; Zhao A; Yang S
Front Vet Sci; 2021; 8():757978. PubMed ID: 34888375
[TBL] [Abstract][Full Text] [Related]
2. Porcine promyelocytic leukemia protein isoforms suppress Japanese encephalitis virus replication in PK15 cells.
Chen Z; Liu H; Zhu J; Duan X; Wang H; Li X; Zhou X; Zhao A; Yang S
Virol J; 2023 Nov; 20(1):280. PubMed ID: 38031162
[TBL] [Abstract][Full Text] [Related]
3. Japanese encephalitis virus perturbs PML-nuclear bodies by engaging in interactions with distinct porcine PML isoforms.
Yang S; Liu H; Chen Z; Wang H; Li X; Zhou X; Zhao A
Front Cell Infect Microbiol; 2023; 13():1239234. PubMed ID: 37928180
[TBL] [Abstract][Full Text] [Related]
4. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
[TBL] [Abstract][Full Text] [Related]
5. The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.
Guion LG; Sapp M
Front Cell Infect Microbiol; 2020; 10():35. PubMed ID: 32154186
[TBL] [Abstract][Full Text] [Related]
6. Sp100 isoform-specific regulation of human adenovirus 5 gene expression.
Berscheminski J; Wimmer P; Brun J; Ip WH; Groitl P; Horlacher T; Jaffray E; Hay RT; Dobner T; Schreiner S
J Virol; 2014 Jun; 88(11):6076-92. PubMed ID: 24623443
[TBL] [Abstract][Full Text] [Related]
7. Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.
Maroui MA; Kheddache-Atmane S; El Asmi F; Dianoux L; Aubry M; Chelbi-Alix MK
PLoS One; 2012; 7(9):e44949. PubMed ID: 23028697
[TBL] [Abstract][Full Text] [Related]
8. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
Negorev DG; Vladimirova OV; Maul GG
J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
[TBL] [Abstract][Full Text] [Related]
9. Viral DNA Binding Protein SUMOylation Promotes PML Nuclear Body Localization Next to Viral Replication Centers.
Stubbe M; Mai J; Paulus C; Stubbe HC; Berscheminski J; Karimi M; Hofmann S; Weber E; Hadian K; Hay R; Groitl P; Nevels M; Dobner T; Schreiner S
mBio; 2020 Mar; 11(2):. PubMed ID: 32184235
[TBL] [Abstract][Full Text] [Related]
10. A Tale of Usurpation and Subversion: SUMO-Dependent Integrity of Promyelocytic Leukemia Nuclear Bodies at the Crossroad of Infection and Immunity.
Patra U; Müller S
Front Cell Dev Biol; 2021; 9():696234. PubMed ID: 34513832
[TBL] [Abstract][Full Text] [Related]
11. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.
Maroui MA; Pampin M; Chelbi-Alix MK
J Virol; 2011 Dec; 85(24):13164-73. PubMed ID: 21994459
[TBL] [Abstract][Full Text] [Related]
13. Implication of PMLIV in both intrinsic and innate immunity.
El Asmi F; Maroui MA; Dutrieux J; Blondel D; Nisole S; Chelbi-Alix MK
PLoS Pathog; 2014 Feb; 10(2):e1003975. PubMed ID: 24586174
[TBL] [Abstract][Full Text] [Related]
14. PML protein isoforms and the RBCC/TRIM motif.
Jensen K; Shiels C; Freemont PS
Oncogene; 2001 Oct; 20(49):7223-33. PubMed ID: 11704850
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of component exchange at PML nuclear bodies.
Weidtkamp-Peters S; Lenser T; Negorev D; Gerstner N; Hofmann TG; Schwanitz G; Hoischen C; Maul G; Dittrich P; Hemmerich P
J Cell Sci; 2008 Aug; 121(Pt 16):2731-43. PubMed ID: 18664490
[TBL] [Abstract][Full Text] [Related]
16. Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.
Geng Y; Monajembashi S; Shao A; Cui D; He W; Chen Z; Hemmerich P; Tang J
J Biol Chem; 2012 Aug; 287(36):30729-42. PubMed ID: 22773875
[TBL] [Abstract][Full Text] [Related]
17. Promyelocytic Leukemia Protein (PML) Requirement for Interferon-induced Global Cellular SUMOylation.
Maroui MA; Maarifi G; McManus FP; Lamoliatte F; Thibault P; Chelbi-Alix MK
Mol Cell Proteomics; 2018 Jun; 17(6):1196-1208. PubMed ID: 29535160
[TBL] [Abstract][Full Text] [Related]
18. Differential Roles of PML Isoforms.
Nisole S; Maroui MA; Mascle XH; Aubry M; Chelbi-Alix MK
Front Oncol; 2013; 3():125. PubMed ID: 23734343
[TBL] [Abstract][Full Text] [Related]
19. C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.
Li C; Peng Q; Wan X; Sun H; Tang J
J Cell Sci; 2017 Oct; 130(20):3496-3506. PubMed ID: 28851805
[TBL] [Abstract][Full Text] [Related]
20. TGF-β induces PML SUMOylation, degradation and PML nuclear body disruption.
El-Asmi F; El-Mchichi B; Maroui MA; Dianoux L; Chelbi-Alix MK
Cytokine; 2019 Aug; 120():264-272. PubMed ID: 31153006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
